Phase 2 B-Cell Lymphoblastic Leukemia Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Acute Lymphoblastic LeukemiaB-Cell Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute60 enrolled1 locationNCT06144606
Recruiting
Phase 1Phase 2
Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital50 enrolled1 locationNCT06880913
Recruiting
Phase 1Phase 2
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology80 enrolled1 locationNCT06735495
Recruiting
Phase 2Phase 3
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
B-Cell Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine90 enrolled4 locationsNCT06607419
Recruiting
Phase 2
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
Precursor B-Cell Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University20 enrolled1 locationNCT06554626
Recruiting
Phase 1Phase 2
CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology80 enrolled1 locationNCT06503094